Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-13-004016
Filing Date
2013-08-08
Accepted
2013-08-08 17:08:44
Documents
15
Period of Report
2013-08-08

Document Format Files

Seq Description Document Type Size
1 TARO PHARMACEUTICAL INDUSTRIES LTD. 6-K a50687516.htm 6-K 256760
2 GRAPHIC a50687516.jpg GRAPHIC 1099
3 LOGO logo.jpg GRAPHIC 3356
4 GRAPHIC a50687516b11.jpg GRAPHIC 338439
5 GRAPHIC a50687516b12.jpg GRAPHIC 354674
6 GRAPHIC a50687516b13.jpg GRAPHIC 374688
7 GRAPHIC a50687516b14.jpg GRAPHIC 205473
8 GRAPHIC a50687516b15.jpg GRAPHIC 378034
9 GRAPHIC a50687516b16.jpg GRAPHIC 266717
10 GRAPHIC a50687516b21.jpg GRAPHIC 337759
11 GRAPHIC a50687516b22.jpg GRAPHIC 314940
12 GRAPHIC a50687516b23.jpg GRAPHIC 353479
13 GRAPHIC a50687516b24.jpg GRAPHIC 277526
14 GRAPHIC a50687516b25.jpg GRAPHIC 399321
15 GRAPHIC a50687516b26.jpg GRAPHIC 283165
  Complete submission text file 0001157523-13-004016.txt   5617578
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35463 | Film No.: 131023079
SIC: 2834 Pharmaceutical Preparations